Dr. Garçon, a biological pharmacist with PhDs in pharmaceutical science and immunotoxicology/immunopharmacology, has extensive experience in vaccine development.

She worked at the Royal Free Hospital London and Baylor College of Medicine before joining GlaxoSmithKline Vaccines in 1990. At GSK, she held various leadership roles, culminating in Vice President, Head of Adjuvants and Technologies Innovation Center.

In 2014, she joined BIOASTER as Chief Scientific Officer, later becoming CEO. Her expertise spans vaccinology research to manufacturing, including immunology, adjuvant technologies, and safety evaluation.

She received the 2014 Stanley Plotkin award, has authored over 70 publications, and holds over 100 patents. Distinctions include Chevalier de la Légion d’honneur and membership in the French Académie of Pharmacie.